NO20084010L - Krystallform av besipirdinklorhydrat, fremgangsmate for fremstilling og bruk derav - Google Patents
Krystallform av besipirdinklorhydrat, fremgangsmate for fremstilling og bruk deravInfo
- Publication number
- NO20084010L NO20084010L NO20084010A NO20084010A NO20084010L NO 20084010 L NO20084010 L NO 20084010L NO 20084010 A NO20084010 A NO 20084010A NO 20084010 A NO20084010 A NO 20084010A NO 20084010 L NO20084010 L NO 20084010L
- Authority
- NO
- Norway
- Prior art keywords
- chlorohydrate
- preparation
- shows
- following
- crystal form
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Abstract
Krystallform av besipiridin-klorhydrat (form I) ifølge formel (A) nedenfor: den ovenfor nevnte form særpreges ved minst én av følgende fysikalsk-kjemiske egenskaper: a) i FTIR viser den i det minste følgende absorpsjonsbånd i det infrarøde spektrum: 778, 1198 og 1121, men ikke følgende absorpsjonsbånd i det infrarøde spektrum: 3395, 1583 og 732, hvor disse båndene nevnt er uttrykt i cm-1 ved ± 5 cm-1 , b) i PXRD viser den i det minste følgende refleksjoner, som er de mest intense, men hvis intensitet i det påfølgende gis for informasjon: Formel (II) c) i DSC viser den i det minste en endoterm topp ved 187,3 ± 2,0 oC ved anvendelse av en temperaturøkning på 5 oC/minutt og en fusjonsentalpi ?H på 130,4 ± 2,0 J/g. Oppfinnelsen gjelder også fremgangsmåtene som anvendes for fremstilling av form I, så vel som anvendelser av dem innen urologien.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0601468A FR2897614B1 (fr) | 2006-02-20 | 2006-02-20 | Forme cristalline du chlorhydrate de la besipirdine, procedes de preparation et utilisations |
US78715706P | 2006-03-30 | 2006-03-30 | |
PCT/IB2007/001456 WO2007096777A2 (en) | 2006-02-20 | 2007-02-20 | Crystal form of besipirdine chlorhydrate, process preparation and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20084010L true NO20084010L (no) | 2008-11-19 |
Family
ID=37309765
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20084010A NO20084010L (no) | 2006-02-20 | 2008-09-19 | Krystallform av besipirdinklorhydrat, fremgangsmate for fremstilling og bruk derav |
Country Status (16)
Country | Link |
---|---|
US (1) | US20090048304A1 (no) |
EP (1) | EP1996575A2 (no) |
JP (1) | JP2009527544A (no) |
KR (1) | KR20080106232A (no) |
CN (1) | CN101384584A (no) |
AU (1) | AU2007219157A1 (no) |
BR (1) | BRPI0707997A2 (no) |
CA (1) | CA2642687A1 (no) |
FR (1) | FR2897614B1 (no) |
IL (1) | IL193191A0 (no) |
MA (1) | MA30220B1 (no) |
MX (1) | MX2008010659A (no) |
NO (1) | NO20084010L (no) |
RU (1) | RU2008133759A (no) |
WO (1) | WO2007096777A2 (no) |
ZA (1) | ZA200806876B (no) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2925355T3 (es) * | 2017-07-03 | 2022-10-17 | Shandong Danhong Pharmaceutical Co Ltd | Forma cristalina y forma amorfa de clorhidrato análogo de dezocina |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4970218A (en) * | 1987-04-24 | 1990-11-13 | Hoechst-Roussel Pharmaceuticals Inc. | N-(pyridinyl)-1H-indol-1-amines |
US5356910A (en) * | 1993-07-19 | 1994-10-18 | Hoechst-Roussel Pharmaceuticals Inc. | Use of N-(pyridinyl)-1H-indol-1-amines for the treatment of obsessive-compulsive disorder |
US5459274A (en) * | 1994-05-13 | 1995-10-17 | Hoechst-Roussel Pharmaceuticals Inc. | Preparation of N-alkyl-N-pyridinyl-1H-indol-1-amines |
CN1184969C (zh) * | 1995-07-27 | 2005-01-19 | 阿温蒂斯药物公司 | 未取代和取代的n-(吡咯-1-基)吡啶胺作为抗惊厥药的用途 |
AR046041A1 (es) * | 2003-10-03 | 2005-11-23 | Aventis Pharma Inc | Procedimiento para la preparacion de compuestos heterociclicos n-amino sustituidos |
-
2006
- 2006-02-20 FR FR0601468A patent/FR2897614B1/fr not_active Expired - Fee Related
-
2007
- 2007-02-20 JP JP2008555899A patent/JP2009527544A/ja not_active Withdrawn
- 2007-02-20 EP EP07734744A patent/EP1996575A2/en not_active Withdrawn
- 2007-02-20 CN CNA2007800059450A patent/CN101384584A/zh active Pending
- 2007-02-20 BR BRPI0707997-4A patent/BRPI0707997A2/pt not_active IP Right Cessation
- 2007-02-20 MX MX2008010659A patent/MX2008010659A/es unknown
- 2007-02-20 KR KR1020087021943A patent/KR20080106232A/ko not_active Application Discontinuation
- 2007-02-20 CA CA002642687A patent/CA2642687A1/en not_active Abandoned
- 2007-02-20 WO PCT/IB2007/001456 patent/WO2007096777A2/en active Application Filing
- 2007-02-20 AU AU2007219157A patent/AU2007219157A1/en not_active Abandoned
- 2007-02-20 RU RU2008133759/04A patent/RU2008133759A/ru not_active Application Discontinuation
- 2007-02-20 US US12/223,602 patent/US20090048304A1/en not_active Abandoned
-
2008
- 2008-07-31 IL IL193191A patent/IL193191A0/en unknown
- 2008-08-08 ZA ZA200806876A patent/ZA200806876B/xx unknown
- 2008-08-15 MA MA31178A patent/MA30220B1/fr unknown
- 2008-09-19 NO NO20084010A patent/NO20084010L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2007096777A2 (en) | 2007-08-30 |
EP1996575A2 (en) | 2008-12-03 |
RU2008133759A (ru) | 2010-03-27 |
FR2897614A1 (fr) | 2007-08-24 |
CA2642687A1 (en) | 2007-08-30 |
MA30220B1 (fr) | 2009-02-02 |
JP2009527544A (ja) | 2009-07-30 |
ZA200806876B (en) | 2009-10-28 |
CN101384584A (zh) | 2009-03-11 |
FR2897614B1 (fr) | 2008-05-23 |
IL193191A0 (en) | 2009-08-03 |
AU2007219157A1 (en) | 2007-08-30 |
MX2008010659A (es) | 2008-09-01 |
BRPI0707997A2 (pt) | 2011-05-17 |
WO2007096777A3 (en) | 2008-01-17 |
US20090048304A1 (en) | 2009-02-19 |
KR20080106232A (ko) | 2008-12-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006122186A3 (en) | 1,4-diphenyl-3-hydroxyalkyl-2-azetidinone derivatives for treating hypercholestrolemia | |
NO20075809L (no) | DNA-PK inhibitorer | |
SI1853602T1 (sl) | Kemične spojine | |
SI1853588T1 (sl) | Kemične spojine | |
WO2007111864A3 (en) | Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use | |
WO2005074607A3 (en) | Method of treating hemolytic disease | |
WO2007109279A3 (en) | Tetrahydropyridothienopyrimidine compounds and methods of use thereof | |
BRPI0417543A (pt) | quinolinas úteis no tratamento de doença cardiovascular | |
WO2005121097A3 (en) | Pyrazole derivatives, compositions containing such compounds and methods of use | |
WO2005110994A8 (en) | Substituted pyrazolyl urea derivatives useful in the treatment of cancer | |
NO20071549L (no) | Nye benzofuserte heteroalrylsulfamidderivater, anvendelige som anti-krampemidler | |
WO2006104826A3 (en) | Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use | |
EA201000050A1 (ru) | Замещенные бициклолактамные соединения | |
EP1740581A4 (en) | PYRIDYL DERIVATIVE COMPOUNDS SUBSTITUTED AT POSITIONS 2, 4, 6 USEFUL AS INHIBITORS OF BETA-SECRETASE IN THE TREATMENT OF ALZHEIMER'S DISEASE | |
MX2009007231A (es) | Compuestos quimicos 637:piridopirimidindionas como inhibidores de la fosfodiesterasa 4. | |
WO2006047288A3 (en) | Asymmetric synthesis of dihydrobenzofuran derivatives | |
WO2006100082A3 (de) | Substituierte oxindol-derivate, diese enthaltende arzneimittel und deren verwendung | |
NO20060360L (no) | Nye 8-azabisyklo [3.2.1] oktanderivater og deres anvendelse som monoaminneurotransmittergjenopptaksinhibitorer | |
EA200601295A1 (ru) | Производные 1,3-диоксана и их аналоги, применимые для лечения i.a. ожирения и диабета | |
WO2007030361A3 (en) | Benzimidazole thiophene compounds as plk inhibitors | |
TW200745044A (en) | Pyrazole derivatives, compositions containing such compounds and methods of use | |
NO20082909L (no) | Fremgangsmate for a utvinne lignan-ekstrakter og sammensetninger inneholdende lignan-ekstraktene | |
EP1817311A4 (en) | 2,3,4,6-SUBSTITUTED PYRIDYL DERIVATIVE COMPOUNDS AS BETA SEKTRETASE INHIBITORS FOR THE TREATMENT OF MORBUS ALZHEIMER | |
MX2010002938A (es) | Derivados de (3-hidroxi-4-amino-butan-2-il)-3-(2-tiazol-2-il-pirro lidin-1-carbonil)benzamida y compuestos relacionados como inhibidores de beta-secretasa para tratar enfermedad de alzheimer. | |
WO2002066035A3 (en) | Azoles as malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |